FTXH

First Trust Nasdaq Pharmaceu

+$7.0M

Net Activity

Institutions Holding

32

Popularity Rank

#7094

Avg Weight

0.03%

Total Value

$18.9M

Ownership Trend

32 institutions currently hold FTXH, with 21 net buyers and 10 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Majority Increased

Based on recent trading activity

Net Selling Institutions

10

Net Buying Institutions

21

Key Holders

View all 32 holding institutions

Quarterly Activity

Recent Activity

+$16.6M

Total Buy Value

$2.5M

Total Sell Value

New buy9
Trim7
Add12
Sold out3

21

Net Buyers

10

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding FIRST TRUST NASDAQ PHARMACEU (FTXH)?
Major stakeholders currently include LPL Financial LLC ($6.1M), Truist Financial CORP ($2.0M), Marshall Investment Management, LLC ($1.6M). Based on the latest 13F filings, there are a total of 32 tracked investment funds and institutions maintaining positions in FTXH.
What is the overall institutional sentiment toward FTXH recently?
Institutional sentiment appears Bullish (Net Buying). During the most recent reporting quarter, the stock experienced a net inflow of $7.0M, driven by 21 managers accumulating shares while 10 reduced their exposure.
Which institutions have been selling or reducing their FTXH positions?
In the latest period, 7 funds trimmed their holdings, and 3 managers completely exited their positions. The aggregate reported sell value was $2.5M.
Are there any notable investors adding FTXH to their portfolios?
Yes, buying activity remains notable. 9 institutions opened new positions in {ticker}, and 12 existing holders added to their shares. The total reported buy value for the quarter amounted to $16.6M.

Related Stocks